Assay miniaturization has become a central strategy in modern high-throughput screening (HTS), enabling laboratories to increase throughput while managing reagent consumption and operational costs. As ...

Miniaturization has become a key strategy in modern assay development — reducing reagent consumption, increasing throughput, and enabling more efficient experimental workflows. However, achieving ...

Cell-Based Assay Platforms are Evolving to Meet Diverse Challenges Cell-based assay platforms are evolving to meet diverse challenges—mimicking disease states, preserving signaling pathways, modeling ...

Assay development and optimization are crucial steps in drug discovery, diagnostics, and life sciences research. As assay complexity and throughput increase, the need for accuracy, efficiency, and ...

This webinar will demonstrate how the MANTIS and TEMPEST liquid dispensers enable assay automation and miniaturization in various applications such as PCR, NGS, immunoassays, and cell and organoid ...

Gprotein-coupled receptors (GPCRs) are an important class of receptor in modern drug discovery. This superfamily of receptors is highly tractable for drug discovery purposes because many of these ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera Biologics Inc., a global leader in therapeutic antibody discovery from natural immune systems, today announced that the U.S. Patent and ...

Adherent cell assays have lagged behind in automation, slowing drug discovery. Semarion’s SemaCyte® microcarrier platform streamlines these workflows by making adherent cells assay-ready, improving ...

SAN CARLOS, Calif., April 1, 2015 -- Curiox Biosystems, a leader in miniaturized multiplex technology, announces two successful research collaborations with the Agency for Science, Technology and ...

Dublin, Nov. 13, 2017 (GLOBE NEWSWIRE) -- The "World Market for Infectious Disease Immunoassays" report has been added to Research and Markets' offering. The World Market for Infectious Disease ...